Greenwich Wealth Management LLC Aspira Women'S Health Inc. Transaction History

Greenwich Wealth Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$0.32 - $0.58 $55,509 - $100,611	-173,468 Reduced 35.09%	320,861 $117,000
Q4 2022 Feb 06, 2023	BUY	$0.3 - $0.41 $5,200 - $7,106	17,334 Added 3.63%	494,329 $164,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $1.07 $6,587 - $18,548	17,335 Added 3.77%	476,995 $178,000
Q2 2022 Aug 08, 2022	BUY	$0.4 - $1.09 $14,587 - $39,750	36,468 Added 8.62%	459,660 $270,000
Q4 2021 Jan 28, 2022	BUY	$1.63 - $3.43 $4,249 - $8,942	2,607 Added 0.62%	423,192 $749,000
Q3 2021 Oct 19, 2021	BUY	$3.19 - $5.48 $7,968 - $13,689	2,498 Added 0.6%	420,585 $1.37 Million
Q2 2021 Jul 27, 2021	BUY	$4.78 - $6.84 $1.53 Million - $2.18 Million	319,397 Added 323.64%	418,087 $2.35 Million
Q1 2021 May 06, 2021	SELL	$5.9 - $9.13 $1,475 - $2,282	-250 Reduced 0.25%	98,690 $666,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $1,500 - $3,355	500 Added 0.51%	98,940 $664,000
Q3 2020 Oct 29, 2020	BUY	$2.54 - $4.56 $53,967 - $96,886	21,247 Added 27.52%	98,440 $304,000
Q2 2020 Aug 11, 2020	BUY	$0.78 - $5.25 $60,210 - $405,263	77,193 New	77,193 $296,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwich Wealth Management LLC with notifications on news.